Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis

BACKGROUND: Plasma concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, are raised in patients with chronic vascular disease, causing increased cardiovascular risk and endothelial dysfunction, but the role of ADMA in acute inflammatory states is les...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Joshua S., Darcy, Christabelle J., Yeo, Tsin W., Jones, Catherine, McNeil, Yvette R., Stephens, Dianne P., Celermajer, David S., Anstey, Nicholas M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041798/
https://www.ncbi.nlm.nih.gov/pubmed/21364995
http://dx.doi.org/10.1371/journal.pone.0017260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041798/
https://www.ncbi.nlm.nih.gov/pubmed/21364995
http://dx.doi.org/10.1371/journal.pone.0017260

Ejemplares similares